Human osteoclasts and preosteoclast cells (FLG 29.1) express functional c-kit receptors and interact with osteoblast and stromal cells via membrane- bound stem cell factor

Cell Growth and Differentiation

Volumn 7, Issue 6, 1996, Pages 753-763

  Gattei, Valter ^a   Aldinucci, Donatella ^a   Quinn, Julian M W ^b   Degan, Massimo ^a   Cozzi, Marzia ^a   Perin, Vilma ^a   De Iuliis, Angela ^a   Juzbasic, Senka ^a   Improta, Salvatore ^a   Athanasou, Nick A ^b   Ashman, Leonie K ^c   Pinto, Antonio ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CELL RECEPTOR; STEM CELL FACTOR;

ARTICLE; BONE CELL; BONE MARROW CELL; BONE REMODELING; CELL INTERACTION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; PROTO ONCOGENE; STROMA CELL;

BONE MARROW; BONE MARROW CELLS; CELL ADHESION; CELL COMMUNICATION; CELL LINE; CELL MEMBRANE; HUMANS; OSTEOBLASTS; OSTEOCLASTS; PROTO-ONCOGENE PROTEINS C-KIT; STEM CELL FACTOR; STEM CELLS; STROMAL CELLS;

EID: 10244225289     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Yarden, Y., Kuang, W. J., Yang-Feng, T., Coussens, L., Munemitsu, S., Dull, T. J., Chen, E., Schlessinger, J., Francke, U., and Ullrich, A. Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J., 6: 3341-3351, 1987.
2. Qui, F., Ray, P., Brown, K., Barker, P. E., Jhanwar, S., Ruddle, F. H., and Besmer, P. Primary structure of c-kit. relationship with the CSF-1/ PDGF receptor kinase family-oncogene activation of v-kit involves deletion of extracellular domain and C terminus. EMBO J., 7: 1003-1011, 1988.
3. Galli, S. J., Zsebo, K. M., and Geissler, E. N. The kit ligand stem cell factor. Adv. Immunol., 55: 1-96, 1994.
4. Zsebo, K. M., Williams, D. A., Geissler, E. N., Broudy, V. C., Martin, F. H., Atkins, H. L., Hsu, R. Y., Birkett, N. C., Okino, K. H., Murdoch, D. C., Jacobsen, F. W., Langley, K. E., Smith, K. A., Takeishi, T., Cattanach, B. M., Galli, S. J., and Suggs, S. V. Stem cell factor is encoded at the SI locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor. Cell, 63: 213-224, 1990.
5. Huang, E., Nocka, K., Beler, D. R., Chu, T. Y., Buck, J., Lahm, H. W., Wellner, D., Leder, P., and Besmer, P. The hematopoietic growth factor KL is encoded by the SI locus and is the ligand of the c-kit receptor, the gene product of the W locus. Cell, 63: 225-233, 1990.
6. Anderson, D. M., Lyman, S. D., Baird, A., Wignall, J. M., Esenman, J., Rauch, C., March, C. J., Boswell, H. S., Gimpel, S. D., Cosman, D., and Williams. D. E. Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane bound and soluble forms. Cell, 63: 235-243, 1990.
7. Witte, O. N. Steel locus defines new multipotent growth factor. Cell, 63: 5-6, 1990.
8. Heinrich, M. C., Dooley, D. C., Freed, A. C., Band, L., Hoatlin, M. E., Keeble, W. W., Peters, S. T., Silvey, K. V., Ey, F. S., Kabat, D., Maziarz, R. T., and Bagby, G. C. Constitutive expression of Steel factor gene by human stromal cells. Blood, 82: 771-783, 1993.
9. Huang, E. J., Nocka, K. H., Buck, J., and Besmer, P. Differential expression and processing of two cell associated forms of the kit-ligand: KL-1 and KL-2. Mol. Biol. Cell., 3: 349-362, 1992.
10. Broxmeyer, H. E., Maze, R., Miyazawa, K., Carow, C., Hendrie, P. C., Coopers, S., Hangoc, G., Vadhan-Ray, S., and Lu, L. The kit receptor and its ligand, steel factor, as regulators of hemopoiesis. Cancer Cells, 3: 480-487, 1991.
11. McNiece, I. K., Langley, K. E., and Zsebo, K. M. Recombinant human steel factor synergizes with GM-CSF, G-CSF, IL-3 and Epo to stimulate human progenitor cells of the myeloid and erythroid lineages. Exp. Hematol., 19: 226-231, 1991.
12. Bernstein, I. D., Andrews, R. G., and Zsebo, K. M. Recombinant human stem cell factor (SCF) enhances the formation of colonies by CD34 and CD34"lin" cells and the generation of colony-forming cell progeny with CD34"lin" cells cultured with interleukin-3, granulocyte colony-stimulating factor, or granulocyte-macrophage colony-stimulating factor. Blood, 77: 2316-2321, 1991.
13. Avraham, H., Scadden, D. T., Chi, S., Broudy, V. C., Zsebo, K. M., and Groopman, J. E. Interaction of human bone marrow fibroblasts with megakaryocytes: role of the c-kit ligand. Blood, 80: 1679-1684, 1992.
14. Massagué, J., and Pandiella, A. Membrane-anchored growth factors. Annu. Rev. Biochem., 62: 515-541, 1993.
15. Lowry, P. A., Deacon, D., Whitefield, P., McGrath, H. E., and Quesenberry, P. J. Stem cell factor induction of in vitro murine hematopoietic colony formation by "subliminal" cytokine combinations: the role of "anchor factor." Blood, 80: 663-669, 1992.
16. Scheven, B. A. A., Visser, J. W. M., and Nijweide, P. J. In vitro osteoclast generation from different bone marrow fractions, including a highly enriched hematopoietic stem cell population. Nature (Lond.), 321: 79-81, 1986.
17. Kurihara, N., Suda, T., Miura, Y., Nakauchi, H., Kodama, H., Hiura, K., Hakeda, Y., and Kumegawa, M. Generation of osteoclasts from isolated hematopoietic progenitor cells. Blood, 74: 1295-1302, 1989.
18. Manolagas, S. C., and Jilka, R. L. Cytokines, hematopoiesis, osteoclastogenesis, and estrogens. Calcif. Tissue Int., 50: 199-202, 1992.
19. Kurihara, N., Civin, C., Roodman, G. D. Osteotropic factor responsiveness of highly purified populations of early and late precursors for human multinucleated cells expressing the osteoclast phenotype. J. Bone Miner. Res., 6: 257-261, 1991.
20. Hattersley, G., Kerby, J. A., and Chambers, T. J. Identification of osteoclast precursors in multilineage hemopoietic colonies. Endocrinology, 128: 259-262, 1991.
21. Mundy, G. R. Cytokines and local factors which affect osteoclast function. Int. J. Cell. Cloning, 10: 215-222, 1992.
22. Takahashi, N., Akatsu, T., Udagawa, N., Sasaki, T., Yamaguchi, A., Moseley, J. M., Martin, T. J., and Suda, T. Osteoblastic cells are involved in osteoclast formation. Endocrinology, 123: 2600-2602, 1988.
23. McSheehy, P. M., and Chambers, T. J. Osteoblastic cells mediate osteoclastic responsiveness to parathyroid hormone. Endocrinology, 118: 824-828, 1986.
24. McSheehy, P. M., Chambers, T. J. 1,25-Dihydroxyvitamin D3 stimulates rat Osteoblastic cells to release a soluble factor that increases osteoclastic bone resorption. J. Clin. Invest., 80: 425-429, 1987.
25. Udagawa, N., Takaashi, N., Akatsu, T., Sasaki, T., Yamaguchi, A., Kodama, H., Martin, T. J., and Suda, T. The bone marrow-derived stromal cell line MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells. Endocrinology, 125: 1805-1813, 1989.
26. Hattersley, G., Chambers, T. J. Generation of osteoclasts from hemopoietic cells and a multipotential cell line in vitro. J. Cell. Physiol., 140: 478-485, 1989.
27. MacDonald, B. R., Mundy, G. R., Clark, S., Wang, E. A., Kuehl, T. J., Stanley, E. R., and Roodman, G. D. Effects of human recombinant CSF-GM and highly purified CSF-1 on the formation of multinucleated cells with osteoclast characteristics in long-term bone marrow cultures. J. Bone Miner. Res., 1: 227-236, 1986.
28. Pfeilschifter, J., Chenu, C., Bird, A., Mundy, G. R., and Roodman, G. D. Interleukin-1 and tumor necrosis factor stimulate the formation of human osteoclast-like cells in vitro. J. Bone Miner. Res., 4: 113-122, 1989.
29. Jilka, R. L., Hangoc, G., Girasole, G., Passeri, G., Williams, D. C., Abrams, J. S., Boyce, B., Broxmeyer, H., and Manolagas, S. C. Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science (Washington DC), 257: 88-91, 1992.
30. Lewis, D. B., Liggitt, D. H., Effmann, E. L., Motley, S. T., Teitelbaum, S. L., Jepsen, K. J., Goldstein, S. A., Bonadio, J., Carpenter, J., and Perlmutter, R. M. Osteoporosis induced in mice by overproduction of interleukin 4. Proc. Natl. Acad. Sci. USA, 90: 11618-11622, 1993.
31. Girasole, G., Passeri, G., Jilka, R. L., and Manolagas, S. C. Interleukin-11: a new cytokine critical for osteoclast development. J. Clin. Invest., 93: 1516-1524, 1994.
32. Gattei, V., Bernabei, P. A., Pinto, A., Bezzini, R., Ringressi, A., Formigli, L., Tanini, A., Attadia, V., and Brandi, M. L. Phorbol ester induced osteoclast-like differentiation of a novel human leukemic cell line (FLG 29.1). J. Cell Biol., 116: 437-447, 1992.
33. Aldinucci, D., Quinn, J. M. W., Degan, M., Juzbasic, S., De Iuliis, A., Improta, S., Pinto, A., and Gattei, V. In vitro cellular systems for studying osteoclast function and differentiation: primary osteoclast cultures and the FLG 29.1 model. In: G. E. Jones (ed.), Methods in Molecular Medicine: Human Cell Culture Protocols, pp. 277-306. Totowa, NJ: Humana Press, Inc., 1996.
34. Formigli, L., Zecchi Orlandini, S., Benvenuti, S., Masi, L., Pinto, A., Gattei, V., Bernabei, P. A., Gehron Robey, P., Collin-Osbody, P., and Brandi, M. L. In vitro structural and functional relationships between preosteoclastic and bone endothelial cells: a juxtacrine model for migration and adhesion of osteoclast precursors. J. Cell. Physiol., 162: 199-212, 1995.
35. Fiorelli, G., Gori, F., Petilli, M., Tanini, A., Benvenuti, S., Serio, M., Bernabei, P. A., and Brandi, M. L. Functional estrogen receptors in a human preosteoclastic cell line. Proc. Natl. Acad. Sci. USA, 92: 2672-2676, 1995.
36. Rodan, S. B., Imai, Y., Thiede, M. A., Wesolowski, G., Thompson, D., Bar-Shavit, Z., Shull, S., Mann, K., and Rodan, G. A. Characterization of a human osteosarcoma cell line (Saos-2) with osteoblastic properties. Cancer Res., 47: 4961-4966, 1987.
37. Athanasou, N. A., Quinn, J., and McGee, O. D. Reactivity of workshop mAb of the myeloid, platelet and non-lineage (CD45, 45R, CD11a, b, c) series with cells in bone and synovium. In: W. Knapp, B. Dorken, W. R. Gilks, E. P. Rieber, R. E. Schmidt, H. Stein, and A. E. G. K. von dem Borne (eds.). Leukocyte Typing IV-White Cell Differentiation Antigens, pp. 921-923. Oxford, United Kingdom: Oxford University Press, 1989.
38. Broudy, V. C., Morgan, D. A., Lin, N., Zsebo, K. M., Jacobsen, F. W., and Papayannopoulou, T. Stem cell factor influences the proliferation and differentiation of the MB-02 human erythroleukemia cell line by binding to a high-affinity c-kit receptor. Blood, 82: 436-444, 1993.
39. Buhring, H. J., Agis, H., Ashman, L., Gattei, V., Kniep, B., Larregina, A., Pinto, A., and Van Den Oord, J. J. SCFR p145 (c-kit): summary report (CD117). In: S. Schlossmann, L. Boumsell, W. Gilks, J. Harlan, T. Kishimoto, C. Morimoto, J. Ritz, S. Shaw, R. Silverstein, T. Springer, T. Tedder, and R. Todd (eds.), Proceedings of the 5th International Workshop on Human Leukocyte Antigens, pp. 1882-1888. Oxford, United Kingdom: Oxford University Press, 1995.
40. Ashman, L. K., Buhring, H. J., Aylett, G. W., Broudy, V. C., and Muller, C. Epitope mapping and functional studies with three monoclonal antibodies to the c-kit receptor tyrosine kinase, YB5.B8, 17F11, and SR-1. J. Cell. Physiol., 158: 545-554, 1994.
41. Abkowitz, J. L., Broudy, V. C., Bennett, L. G., Zsebo, K. M., and Martin, F. H. Absence of abnormalities of c-kit or its ligand in two patients with Diamond-Blackfan anemia. Blood, 79: 25-28, 1992.
42. Asano, Y., Brach, M. A., Ahlers, A., de Vos, S., Butterfield, J. H., Ashman, L. K., Valent, P., Gruss, H. J., and Herrmann, F. Phorbol ester 12-O-tetradecanoylphorbol-13-acetate down-regulates expression of the c-kit proto-oncogene product. J. Immunol., 151: 2345-2354, 1993.
43. Takahashi, N., Kukita, T., MacDonald, B. R., Bird, A., Mundy, G. R., McManus, L. M., Miller, M., Boyde, A., Jones, S. J., and Roodman, G. D. Osteoclast-like cells form in long-term human bone marrow but not in peripheral blood cultures. J. Clin. Invest., 83: 543-550, 1989.
44. Demulder, A., Suggs, S. V., Zsebo, K. M., Scarcez, T., and Roodman, G. D. Effects of stem cell factor or osteoclast-like cell formation in long-term human marrow cultures. J. Bone Miner. Res., 7: 1337-1344, 1992.
45. + fraction of adult human bone marrow contains the osteogenic precursors. Blood, 84: 4164-4173, 1994.
46. Goldring, S. T., Shiller, A. L., Mankin, J. J., Dayer, M. M., and Krane, S. M. Characterization of cells from human giant cell tumors of bone Clin. Orthop. Rel. Res., 204: 59-75, 1986.
47. Kinashi, T., and Springer, T. A. Steel factor and c-kit regulate cell-matrix adhesion. Blood, 83: 1033-1038, 1994.
48. Taichman, R. S., and Emerson, S. G. Human osteoblasts support hematopoiesis through the production of granulocyte colony-stimulating factor. J. Exp. Med., 179: 1677-1682, 1994.
49. Oreffo, R. O. C., Marshall, J., Kirchen, C., Garcia, M., Gallwitz, W., Mundy, G. R., and Bonewald, L. F. Characterization of a cell line derived from a human giant cell tumor that stimulates osteoclastic bone resorption. Clin. Orthop. Rel. Res., 296: 229-241, 1893.
50. Frame, B., and Nixon, R. K. Bone marrow mast cells in osteoporosis of aging. N. Engl. J. Med., 279: 626-630, 1968.
51. Fallon, M. D., Whyte, M. P., and Teitelbaum, S. L. Systemic mastocytosis associated with generalized osteopenia. Hum. Pathol., 12: 813-820, 1981.
52. Cozzolino, F., Torcia, M., Aldinucci, D., Rubartelli, A., Miliani, A., Shaw, A. R., Lansdorp, P. M., and Di Guglielmo, R. Production of interleukin-1 by bone marrow myeloma cells. Blood, 74: 380-387, 1989.
53. Lemoli, R. M., Fortuna, A., Grande, A., Gamberi, B., Bonsi, L., Fogli, M., Amabile, M., Cavo, M., Ferrari, S., and Tura, S. Expression and functional role of c-kit ligand (SCF) in human multiple myeloma. Br. J. Haematol., 88: 760-769, 1994.
54. Pinto, A., Aldinucci, D., Gattei, V., Zagonel, V., Tortora, G., Budillon, A., and Cho-Chung, Y. S. Inhibition of self-renewal capacity of blast progenitors from acute myeloblastic leukemia patients by site-selective 8-chloroadenosine 3′,5′-cyclic monophosphate. Proc. Natl. Acad. Sci. USA, 89: 8884-8888, 1993.
55. Carbone, A., Gloghini, A., Gattei, V., Aldinucci, D., Degan, M., De Paoli, P., Zagonel, V., and Pinto, A. Expression of functional CD40 antigen on Reed-Sternberg cells and Hodgkin's disease cell lines. Blood, 85: 780-789, 1995.
56. Pinto, A., Gloghini, A., Gattei, V., Aldinucci, D., Zagonel, V., and Carbone, A. Expression of the c-kit receptor in human lymphomas is restricted to Hodgkin's disease and CD30+ anaplastic large cell lymphomas. Blood, 83: 785-792, 1994.
57. Manfioletti, G., Gattei, V., Buratti, E., Rustighi, A., De Iuliis, A., Aldinucci, D., Goodwin, G. H., and Pinto, A. Differential expression of a novel proline-rich homeobox gene (Prh) in human hematolymphopoietic cells. Blood, 85: 1237-1245, 1995.
58. Pinto, A., Gattei, V., Soligo, D., Parravicini, C., and Del Vecchio, L., New molecules burst at the cell surface. Leukemia (Baltimore), 8: 347-358, 1994.
59. Reisbach, G., Bartke, I., Kempkes, B., Kostka, G., Ellwart, J., Birner, A., Thalmeier, K., Mailhammer, R., Bornkamm, G. W., Ullrich, A., and Dormer, P. Characterization of hemopoietic cell populations from human cord blood expressing c-kit. Exp. Hematol., 21: 74-79, 1993.
60. Gatter, K. C., Falini, B., and Mason, D. Y. The use of monoclonal antibodies in histological diagnosis. In: P. P. Anthony and R. N. M. Mac-Sween (eds.), Recent Advances in Histopathology, No. 12, pp. 35-67. Edinburgh, United Kingdom: Churchill Livingston, 1984.
61. Chomczynski, P., and Sacchi, N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.